KalVista Pharmaceuticals (KALV) Earnings Date, Estimates & Call Transcripts

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free KALV Stock Alerts

$11.74

-0.15 (-1.26%)

(As of 04/15/2024 ET)

Compare

Upcoming Earnings Date: Jul. 5Estimated
Actual EPS (Mar. 11): -$0.84 Missed By -$0.09
Consensus EPS (Mar. 11): -$0.75

Earnings Per Share Revenue

KALV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KALV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.

KalVista Pharmaceuticals Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	($1.14)	($0.73)	($0.94)
Q2 2024	3	($0.94)	($0.66)	($0.79)
Q3 2024	3	($0.98)	($0.69)	($0.82)
Q4 2024	3	($1.03)	($0.55)	($0.78)
FY 2024	11	($4.09)	($2.63)	($3.33)
Q1 2025	1	($0.57)	($0.57)	($0.57)
Q2 2025	1	($0.54)	($0.54)	($0.54)
Q3 2025	1	($0.53)	($0.53)	($0.53)
Q4 2025	1	($0.50)	($0.50)	($0.50)
FY 2025	4	($2.14)	($2.14)	($2.14)

KALV Earnings Date and Information

KalVista Pharmaceuticals last released its earnings results on March 11th, 2024. The specialty pharmaceutical company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.75) by $0.09. KalVista Pharmaceuticals has generated ($3.15) earnings per share over the last year (($3.15) diluted earnings per share). Earnings for KalVista Pharmaceuticals are expected to grow in the coming year, from ($3.05) to ($2.53) per share. KalVista Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 5th, 2024 based off prior year's report dates.

KalVista Pharmaceuticals Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
7/5/2024 Estimated)	-	-	-	-	-	-	-
3/11/2024	Q3 2024	($0.75)	($0.84)	($0.09)	($0.84)	-	-
12/7/2023	Q4 2023	($0.76)	($0.80)	($0.04)	($0.80)	-	-
9/7/2023	Q3 2023	($0.86)	($0.74)	+$0.12	($0.74)	-	-
7/7/2023	Q2 2023	($0.87)	($0.77)	+$0.10	($0.77)	-	-
3/9/2023	Q3 2023	($0.97)	($0.75)	+$0.22	($0.75)	-	-
12/8/2022	Q2 2023	($1.04)	($0.90)	+$0.14	($0.90)	-	-
Get the Latest News and Ratings for KALV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
9/8/2022	Q1 2023	($1.02)	($0.94)	+$0.08	($0.94)	-	-
7/7/2022	Q4 2022	($1.06)	($0.98)	+$0.08	($0.98)	-	-
3/10/2022	Q3 2022	($0.91)	($0.92)	($0.01)	($0.92)	-	-
12/9/2021	Q2	($0.7910)	($0.80)	($0.0090)	($0.80)	-	-
9/8/2021	Q3 2021	($0.71)	($0.66)	+$0.05	($0.66)	-	-
7/12/2021	Q2 2021	($0.56)	($0.65)	($0.09)	($0.65)	-	-

KalVista Pharmaceuticals Earnings - Frequently Asked Questions

When is KalVista Pharmaceuticals's earnings date?: KalVista Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 5th, 2024 based off last year's report dates. Learn more on KALV's earnings history.
Did KalVista Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, KalVista Pharmaceuticals (NASDAQ:KALV) missed the analysts' consensus estimate of ($0.75) by $0.09 with a reported earnings per share (EPS) of ($0.84). Learn more on analysts' earnings estimate vs. KALV's actual earnings.
How much profit does KalVista Pharmaceuticals generate each year?: KalVista Pharmaceuticals (NASDAQ:KALV) has a recorded net income of -$92.91 million. KALV has generated -$3.15 earnings per share over the last four quarters.
What is KalVista Pharmaceuticals's EPS forecast for next year?: KalVista Pharmaceuticals's earnings are expected to grow from ($3.05) per share to ($2.53) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:KALV) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

KalVista Pharmaceuticals (KALV) Earnings Date, Estimates & Call Transcripts

KALV Earnings Estimates and Actuals by Quarter

KALV Estimated and Actual Revenue by Quarter

KalVista Pharmaceuticals Analyst EPS Estimates

KALV Earnings Date and Information

KalVista Pharmaceuticals Earnings History by Quarter

KalVista Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KalVista Pharmaceuticals (KALV) Earnings Date, Estimates & Call Transcripts

Earnings Summary

KALV Earnings Estimates and Actuals by Quarter

KALV Estimated and Actual Revenue by Quarter

KalVista Pharmaceuticals Analyst EPS Estimates

KALV Earnings Date and Information

KalVista Pharmaceuticals Earnings History by Quarter

KalVista Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat